Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: Type I cells generate GVL and type II cells abrogate GVL

Biology of Blood and Marrow Transplantation

Volumn 2, Issue 3, 1996, Pages 118-125

  Fowler, Daniel H ^a   Breglio, Jeffrey ^a   Nagel, Gregg ^a   Hirose, Christopher ^a   Gress, Ronald E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CTL; Graft vs. leukemia effect; Th1 Th2

Indexed keywords

ALLOANTIGEN; CYTOKINE; INTERLEUKIN 10;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BIOSYNTHESIS; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CYTOLOGY; CYTOTOXICITY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL LEUKEMIA; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; RABBIT; SECRETION; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANIMALS; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-10; ISOANTIGENS; LEUKEMIA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RABBITS; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030252711     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Truitt RL, Johnson BD: Principles of graft-vs.-leukemia reactivity. Biol Blood Marrow Transplant 1:61, 1995.
2. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145, 1989.
3. Croft M, Carter L, Swain SL, Dutton RW: Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 180:1715, 1994.
4. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271, 1995.
5. + T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow. Bone Marrow Transplant 8:51, 1991.
6. Korngold R, Leighton C, Manser T: Graft-versus-myeloid leukemia responses following syngeneic and allogeneic bone marrow transplantation. Transplantation 58:278, 1994.
7. BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene 9:149, 1994.
8. + cells of an antigen not associated with the T cell receptor complex but involved in T cell activation. J Immunol 139:1214, 1987.
9. + subset of mature T lymphocytes. J Immunol 138:1, 1987.
10. Ohara J, Paul WE: Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:333, 1985.
11. Wunderlich J, Shearer G: Induction and measurement of cytotoxic T lymphocyte activity. In: JE Coligan, AM Kruisbeek, DH Marguilies, EM Shevach, W Strober (eds) Current Protocols in Immunology. New York: Wiley and Sons, 3.11.4, 1992.
12. Marshak-Rothstein A, Fink P, Gridley T, Raulet DH, Bevan MJ, Gefter ML: Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus. J Immunol 122:2491, 1979.
13. + T cells. J Immunol 154:5071, 1995.
14. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE: Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 172:921, 1990.
15. Sad S, Mosmann TR: Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J Immunol 153:3514, 1994.
16. Gajewski TF, Renauld JC, Van Pel A, Boon T: Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. J Immunol 154:5637, 1995.
17. Fowler DH, Breglio J, Nagel G, Eckjaus MA, Gress RE: Allospecific CD8+ Tcl and Tc2 populations in GVL and GVHD. J Immunol 157 (in press), 1996.
18. Matulonis U, Dosiou C, Freeman G, Lamont C, Mauch P, Nadler LM, Griffin JD: B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity: further evidence that B7-1 and B7-2 are functionally distinct. J Immunol 156:3:1126, 1996.
19. Fowler DH, Gress RE: GVHD as a Th1-type process: Regulation by cells of Th2 cytokine phenotype. In: S Burakoff, HJ Deeg, J Ferrara, K Atkinson (eds) Graft-vs-Host Disease: Immunology, Pathophysiology, and Treatment. 2nd ed. New York: Marcel Decker, 479, 1996.
20. + T cells from T cell receptor transgenic mice. J Exp Med 176:1091, 1992.
21. Hsieh CS, Heimberger AB, Gold JS, O'Garra A, Murphy KM: Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc Natl Acad Sci USA 89:6065, 1992.
22. Nagelkerken L, Gollob KJ, Tielemans M, Coffman RL: Role of transforming growth factor-beta in the preferential induction of T helper cells of type 1 by staphylococcal enterotoxin B. Eur J Immunol 23:2306, 1993.
23. + tumor-infiltrating lymphocytes. J Exp Med 173:647, 1991.
24. Nakajima H, Park HL, Henkart PA: Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin. J Exp Med 181:1037, 1995.
25. Rensing-Ehl A, Frei K, Flury R, Matiba B, Mariani SM, Weller M, Aebischer P, Krammer PH, Fontana A: Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur J Immunol 25:2253, 1995.
26. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528, 1994.
27. Cohen P: A role of T cell subsets in tumor immunity. In: VT DeVita, S Hellman, SA Rosenberg (eds) Biologic Therapy of Cancer. 4th ed. Philadelphia: J.B. Lippincott, p. 1, 1994.
28. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH: Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 6:1545, 1994.
29. + lymphoid engraftment. J Immunol 152:1004, 1994.
30. Fowler DH, Kurasawa K, Smith R, Eckhaus MA, Gress RE: Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 84:3540, 1994.
31. + donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 155:585, 1995.
32. Oswald IP, Wynn TA, Sher A, James SL: Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci USA 89:8676, 1992.
33. Powrie F, Menon S, Coffman RL: Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 23:3043, 1993.
34. 2 inhibits TNF-alpha release via a mechanism involving IL-10. J Immunol 154:3383, 1995.
35. Go C, Lancki DW, Fitch FW, Miller J: Anergized T cell clones retain their cytolytic ability. J Immunol 150:367, 1993.